Skip to main content


Peer Review reports

From: Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease

Original Submission
13 Sep 2011 Submitted Original manuscript
27 Jan 2012 Reviewed Reviewer Report - Rudolf P. W├╝thrich
8 Feb 2012 Reviewed Reviewer Report - Andreas Serra
Resubmission - Version 2
Submitted Manuscript version 2
4 Apr 2012 Editorially accepted
4 Apr 2012 Article published 10.1186/1471-2369-13-17

You can find further information about peer review here.

Back to article page